Join Dementia Research News
Reflections on five years of Join Dementia Research
24 February 2020
To mark the fifth anniversary of Join Dementia Research, we asked some of the people closest to the service to share their thoughts on how far Join Dementia Research has come.
5 years of bringing researchers and volunteers together
Today, Monday 24 February 2020, Join Dementia Research celebrates its fifth birthday. We’re not asking for gifts or cards for our fifth birthday. Instead, you can help us celebrate by sending a digital greeting card to someone you know who might be interested in research.
The Global Brain Health Survey – take part today
10 January 2020
The Global Brain Health Survey is an anonymous online survey to learn about people’s views on the brain and brain health. Researchers hope that gathering the opinions and attitudes of people worldwide could help shape future policy recommendations to help everyone take care of their brain in a way that fits their daily life. The survey takes approximately 15 minutes to complete, and anyone over the age of 18 can participate.
Free online course: What is Health Research?
29 October 2019
The NIHR Clinical Research Network has launched a new online course called ‘What is Health Research?’. The three week Massive Open Online Course, or MOOC, is aimed at anyone with a keen interest in learning more about the world of health research. Learners can complete the course at their own pace for free, starting on Monday 11 November 2019.
Dementia fears for former footballers
25 October 2019
A recent study has found that the risk of dying from neurodegenerative disease is almost 3.5 times higher for footballers. However research is at an early stage and there’s currently no suggestion that anyone should stop playing football. Regular physical activity – including football – is a good way to reduce the risk of dementia and conditions such as heart disease.
In the news: Potential new drug may slow Alzheimer’s disease
23 October 2019
US pharmaceutical company Biogen has announced that they plan to ask US drug regulators to approve their experimental Alzheimer’s drug, aducanumab. Aducanumab is designed to target amyloid, a protein that builds up in the brains of people with the early stages of Alzheimer’s disease. The announcement follows Phase III clinical trials called ENGAGE and EMERGE. New analysis of trial data has produced promising results – those who received high doses of aducanumab showed significant slowing in the decline of their cognitive ability.
What’s that study? PREDICT-PD
21 October 2019
PREDICT-PD is a ground-breaking project using simple tests to identify people at higher risk of Parkinson’s disease before the symptoms appear.
Vote for Join Dementia Research!
27 September 2019
We are excited to share that Join Dementia Research has been selected as a #MadeAtUCL Top 100 Innovation. #MadeAtUCL is a new campaign which aims to bring to life University College London’s (UCL) impact on people, lives and communities, mainly through ground-breaking research and discoveries. We would be very grateful for your vote – this will help continue to raise the profile of dementia and research, and help more people to take part.
Electromagnetic ‘bathing cap’ shows promise in early Alzheimer’s disease trial
23 September 2019
In a new study, researchers designed a bathing cap-style head device, called the MemorEM, which was used to deliver electromagnetic waves to the brain. The purpose of this was to try to dissolve what are known as oligomers – groups of abnormal proteins – as they were forming. There was some sign of improvements on tests of thinking and memory in most of the people taking part in the study. This is an experimental, early-stage study that looked primarily at safety, so it cannot tell us for sure if the treatment works.
Help shape future dementia treatments
21 August 2019
Alzheimer’s Research UK have launched a new nationwide survey to help shape future treatments for dementia. The online survey needs everyone’s views on the aspects of daily life that are most important, and which you would most like to protect if you were to develop a disease that causes dementia. Take part today.